Christopher D. Roberts Black Diamond Therapeutics, Inc. (BDTX) insider trading activity

BDTX Quotes by TradingView

Christopher D. Roberts is Chief Scientific Officer of Black Diamond Therapeutics, Inc.. Currently has a direct ownership of 3,200 shares of BDTX, which is worth approximately $8,736. The most recent transaction as insider was on May 03, 2021, when has been sold 2,500 shares (Common Stock) at a price of $26.64 per share, resulting in proceeds of $66,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.2K
0% 3M change
0% 12M change
Total Value Held $8,736

Christopher D. Roberts Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 03 2021
SELL
Open market or private sale
$66,600 $26.64 p/Share
2,500 Reduced 43.86%
3,200 Common Stock
May 03 2021
BUY
Exercise of conversion of derivative security
$27,150 $10.86 p/Share
2,500 Added 30.49%
5,700 Common Stock
Apr 05 2021
SELL
Open market or private sale
$63,850 $25.54 p/Share
2,500 Reduced 43.86%
3,200 Common Stock
Apr 05 2021
BUY
Exercise of conversion of derivative security
$27,150 $10.86 p/Share
2,500 Added 30.49%
5,700 Common Stock
Mar 03 2021
SELL
Open market or private sale
$65,525 $26.21 p/Share
2,500 Reduced 43.86%
3,200 Common Stock
Mar 03 2021
BUY
Exercise of conversion of derivative security
$27,150 $10.86 p/Share
2,500 Added 30.49%
5,700 Common Stock
Feb 03 2021
SELL
Open market or private sale
$63,375 $25.35 p/Share
2,500 Reduced 43.86%
3,200 Common Stock
Feb 03 2021
BUY
Exercise of conversion of derivative security
$27,150 $10.86 p/Share
2,500 Added 30.49%
5,700 Common Stock
Jan 04 2021
SELL
Open market or private sale
$78,875 $31.55 p/Share
2,500 Reduced 43.86%
3,200 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$27,150 $10.86 p/Share
2,500 Added 30.49%
5,700 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
$34,752 $10.86 p/Share
3,200 Added 50.0%
3,200 Common Stock
Dec 03 2020
SELL
Open market or private sale
$81,050 $32.42 p/Share
2,500 Reduced 100.0%
0 Common Stock
Dec 03 2020
BUY
Exercise of conversion of derivative security
$27,150 $10.86 p/Share
2,500 Added 50.0%
2,500 Common Stock
Nov 11 2020
SELL
Open market or private sale
$174,500 $34.9 p/Share
5,000 Reduced 100.0%
0 Common Stock
Nov 11 2020
BUY
Exercise of conversion of derivative security
$54,300 $10.86 p/Share
5,000 Added 50.0%
5,000 Common Stock
Nov 03 2020
SELL
Open market or private sale
$79,875 $31.95 p/Share
2,500 Reduced 100.0%
0 Common Stock
Nov 03 2020
BUY
Exercise of conversion of derivative security
$27,150 $10.86 p/Share
2,500 Added 50.0%
2,500 Common Stock
Oct 05 2020
SELL
Open market or private sale
$78,975 $31.59 p/Share
2,500 Reduced 100.0%
0 Common Stock
Oct 05 2020
BUY
Exercise of conversion of derivative security
$27,150 $10.86 p/Share
2,500 Added 50.0%
2,500 Common Stock
CDR

Christopher D. Roberts

Chief Scientific Officer
Cambridge, MA

Track Institutional and Insider Activities on BDTX

Follow Black Diamond Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDTX shares.

Notify only if

Insider Trading

Get notified when an Black Diamond Therapeutics, Inc. insider buys or sells BDTX shares.

Notify only if

News

Receive news related to Black Diamond Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BDTX